Bellevue Life Sciences Acquisition Corp.
Financial ratios & Valuation

Historical Multiples (2020 – 2023)

2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.34K-24.21K-2.58K146.22N/A-13.39K
Price/Sales ratio
N/AN/AN/AN/AN/AN/A
Price/Book Value ratio
67.07K-37.77K-2.43K1.81N/A-20.10K
Price/Cash Flow ratio
-3.34K-173.73K-21.59K-72.10N/A-97.66K
Price/Free Cash Flow ratio
-3.34K-173.73K-21.59K-72.10N/A-97.66K
Price/Earnings Growth ratio
N/A279.36-2.95-0.07N/A138.20
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A
Effective Tax Rate
866.35%7151.02%645.65%57.25%N/A3898.33%
Return on Assets
-7.37%-0.46%-2.88%1.10%N/A-1.67%
Return On Equity
-2004.37%156.03%94.34%1.24%N/A125.19%
Return on Capital Employed
-2004.20%156.03%94.34%-5.29%N/A125.19%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A
Quick Ratio
0.190.000.090.01N/A0.05
Cash ratio
0.190.000.090.00N/A0.05
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.920.560.97N/AN/A0.77
Debt Equity Ratio
252.52-188.67-31.99N/AN/A-110.33
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.991.001.03N/AN/A1.01
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.07-0.00-0.00N/AN/A-0.00
Company Equity Multiplier
271.67-332.58-32.681.12N/A-182.63
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111.00N/A1
Cash Flow Coverage Ratio
-0.07-0.00-0.00N/AN/A-0.00
Short Term Coverage Ratio
-0.07-0.00-0.00N/AN/A-0.00
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A